Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing ...

Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head ...

Life sciences business Cytiva is set to launch its new platform, designed to accelerate the manufacturing process for ...

Abzena, an end-to-end CDMO for biologics and bioconjugates, will be presenting its latest AbZelect and AbZelectPRO cell line ...

Hazel Jones is the interim CEO and chief operations officer at Enhanc3D Genomics. We sat down with her to discuss her leap of ...

Alchemab Therapeutics, an antibody discovery firm known for identifying natural antibodies in disease-resistant individuals, ...

Cambridge-based drug discovery firm Cresset Group has bolstered its global footprint with the establishment of a new Indian ...

Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people irrespective of the amount ...

In this interview, we delve into the world of bioprocessing with Himanshu Gadgil, the CEO of Enzene Biosciences. With a rich ...

Regeneron Pharmaceuticals’ gene therapy for otoferlin-related hearing loss, a genetic cause of deafness, has restored hearing ...

Key competitors include Boehringer Ingelheim’s cathepsin C inhibitor BI-1291583, Regeneron’s anti-IL-33 monoclonal antibody ...

Circio, a biotech firm specializing in circular RNA-based gene therapy, has unveiled two posters showcasing in vivo ...